| Income Statement |
| Total Revenue | 358.01M |
|
| Revenues (USD) | 358.01M |
| Cost of Revenue | 89.11M |
| Gross Profit | 268.89M |
| Operating Expenses | 267.15M |
| Research and Development Expense | 80.03M |
| Selling, General and Administrative Expense | 187.12M |
| Operating Income | 1.75M |
| Income Tax Expense | 1.68M |
| Net Income | 9.04M |
| Net Income Common Stock | 9.04M |
| Net Income Common Stock (USD) | 9.04M |
| Consolidated Income | 9.04M |
| Earnings per Basic Share | 0.03 |
| Earnings per Basic Share (USD) | 0.03 |
| Earnings per Diluted Share | 0.03 |
| Earning Before Interest & Taxes (EBIT) | 10.72M |
| Earning Before Interest & Taxes (USD) | 10.72M |
| Weighted Average Shares | 304.34M |
| Weighted Average Shares Diluted | 305.80M |
| Balance Sheet |
| Cash and Equivalents | 985.33M |
| Cash and Equivalents (USD) | 985.33M |
| Trade and Non-Trade Receivables | 72.30M |
| Current Assets | 1.15B |
| Property, Plant & Equipment Net | 180.59M |
| Total Assets | 1.52B |
| Debt Current | 23.97M |
| Total Debt | 117.21M |
| Current Liabilities | 271.05M |
| Debt Non-Current | 93.24M |
| Total Liabilities | 370.16M |
| Accumulated Retained Earnings (Deficit) | -867.91M |
| Shareholders Equity | 1.15B |
| Shareholders Equity (USD) | 1.15B |
| Assets Non-Current | 377.13M |
| Total Debt (USD) | 117.21M |
| Deferred Revenue | 111.49M |
| Liabilities Non-Current | 99.11M |
| Trade and Non-Trade Payables | 21.61M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 13.33M |
| Net Cash Flow from Financing | -98.85M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -80.28M |
| Capital Expenditure | -15.23M |
| Issuance (Purchase) of Equity Shares | -96.05M |
| Net Cash Flow from Investing | -15.72M |
| Net Cash Flow from Operations | 34.28M |
| Share Based Compensation | 41.80M |